News & Events
- October 13, 2015
-
October 7, 2015
PD Imaging Biomarker Team at European Medicines Agency (EMA)
Experts of the Parkinson’s disease imaging biomarker team participated in a Scientific Advice meeting at the European Medicines Agency on October 7th 2015. The purpose of this meeting was to review the evidence provided to the Agency that supports the use of Molecular Imaging of the Dopamine Transporter as an enrichment biomarker in clinical trials... -
October 1, 2015
Global Collaboration to Develop New and Existing Drugs for Neonates
Davis JM, Turner MA. Global Collaboration to Develop New and Existing Drugs for Neonates. JAMA pediatrics. 2015 Oct;169(10):887–8. -
October 1, 2015
A Collaborative Approach for “ReSeq-Ing” Mycobacterium Tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers
Schito M, Dolinger DL. A Collaborative Approach for “ReSeq-Ing” Mycobacterium Tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers. EBioMedicine. 2015 Oct;2(10):1262–5.
-
September 25, 2015
Drug Development Tools for Kidney Disease: DDT-KD Consortium Planning Meeting
On September 25th, the Critical Path Institute (C-Path), in partnership with Dr. Chirag Parikh (Yale University) and Dr. Kumar Sharma (University of California, San Diego), sponsored a meeting to launch the Drug Development Tools for Kidney Disease (DDT-KD) Consortium. Dr. Amy Porter (C-Path) will work with Dr. Parikh and Dr. Sharma as Co-Directors of this...
